The Department of Defense has partnered with a third-party lab to test generic medications over concerns of tainted drugs. The DEA is weighing a special registration that would allow some physicians to prescribe controlled medications through telehealth appointments. And, CMS updates its HCAHPS patient experience survey. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
